These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15357465)
1. Delaying Alzheimer's. In a new study, Aricept held it off for 18 months. Is this drug right for you? Gupta S Time; 2004 Aug; 164(5):84. PubMed ID: 15357465 [No Abstract] [Full Text] [Related]
2. Drug may slow brain shrinkage in pre-Alzheimer's disease. Mayo Clin Health Lett; 2006 Dec; 24(12):4. PubMed ID: 17304693 [No Abstract] [Full Text] [Related]
3. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory. Baxter T; Black D; Prempeh H BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011 [No Abstract] [Full Text] [Related]
10. Common Alzheimer's drug flunks test of effectiveness. Initial improvements in cognitive ability made by cholinesterase inhibitors soon disappear. Health News; 2004 Oct; 10(10):11. PubMed ID: 15584119 [No Abstract] [Full Text] [Related]
11. Donepezil in the treatment of patients with Alzheimer's disease. Tsuno N Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770 [TBL] [Abstract][Full Text] [Related]
12. [Post-marketing observational study of donepezil]. Ibach B Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820 [No Abstract] [Full Text] [Related]
13. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60]. Vollmar HC; Butzlaff M Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187 [No Abstract] [Full Text] [Related]
14. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project. Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851 [No Abstract] [Full Text] [Related]
15. First drug for moderate-to-severe Alzheimer's. FDA Consum; 2004; 38(1):3. PubMed ID: 15032183 [No Abstract] [Full Text] [Related]
16. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment. Small BJ; Gagnon E; Robinson B Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315 [TBL] [Abstract][Full Text] [Related]
17. Donepezil for Alzheimer's disease. Benjamin B; Burns A Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763 [TBL] [Abstract][Full Text] [Related]
18. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis. Harry RD; Zakzanis KK Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322 [TBL] [Abstract][Full Text] [Related]
19. Ignoring the controversies: newspaper reports on Alzheimer's disease treatments. Adelman EE; Karlawish JH J Am Geriatr Soc; 2003 Dec; 51(12):1821-2. PubMed ID: 14687373 [No Abstract] [Full Text] [Related]